Where DNA Breaks
Our Insight Begins

Welcome to intoDNA, the pioneering DNA quality diagnostics company transforming DNA damage detection through the revolutionary technology, STRIDE™.

Leverage STRIDE™ through our end-to-end service for precision biomarker discovery and informed decision-making in targeted therapeutics development and patient selection.
hero image

Where DNA Breaks
Our Insight Begins

Welcome to intoDNA, the pioneering DNA quality diagnostics company transforming DNA damage detection through the revolutionary technology, STRIDE™.

Leverage STRIDE™ through our end-to-end service for precision biomarker discovery and informed decision-making in targeted therapeutics development and patient selection.

GET TO KNOW OUR PLATFORM

STRIDE™ Spotlight

image
icon

Direct

The technology directly detects free DNA ends in situ

icon

Quantitative

Automated and objective quantification of fluorescent foci by in-house built AI algorithms

icon

Compatible

Applicable with various types of biological material, including patient-derived tissue samples

icon

Sensitive

Reliable measurement of DNA damage at individual lesion level

icon

Specific

Selective detection of single-, double-, or repair protein-associated DNA breaks

intoDNA as a Partner

Expertise


STRIDE™, powered by intoDNA’s expertise, delivers advanced DNA damage analysis. Our proven track record in targeted therapeutics development ensures you gain critical insights for informed decision-making at every stage.

Services


Elevate your research outcomes with our end-to-end service tailored to your specific project requirements. We seamlessly integrate with your chosen biological model and multiplex our assays to harness the full potential of your research initiatives.

Mission


At intoDNA, our unwavering commitment is to deliver cutting-edge, innovative DNA damage diagnostics solutions wherever the integrity of DNA plays a critical role. We are the trusted partner for scientists seeking to unravel the intricacies of DNA damage and its far-reaching impacts.

Global Expertise

We support top pharmaceutical companies, small-to-mid-sized biotechs and research laboratories across the globe.

0.5K+

satisfied
scientists

100+

tested therapeutic
candidates

10K+

processed sample images over the last two years

7/10

partnered with 7 out of 10
top big pharma

0.5K+

satisfied
scientists

100+

tested therapeutic
candidates

10K+

processed sample images over the last two years

7/10

partnered with 7 out of 10
top big pharma
NEWSROOM

Latest News

Nov 17, 2023

STRIDE validated in human in-vivo samples in collaboration with AstraZeneca

In collaboration with AstraZeneca, intoDNA has validated STRIDE as a groundbreaking tool for quantification of DNA breaks in different types of human clinical samples.
Nov 17, 2023

STRIDE validated in human in-vivo samples in collaboration with AstraZeneca

Nov 03, 2023

intoDNA exhibits at SITC 2023, the premier cancer immunotherapy conference

Jul 11, 2023

intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)

image

Let’s talk about your project

Schedule a meeting with our scientific experts!